异维A酸糖基衍生物的合成及其细胞毒活性研究

采用两种方法合成了2类新的异维A酸糖基衍生物(5a~5d, 6a, 10a~10c, 11a), 并进行了结构表征与确认. 采用MTT法测试了它们对肺癌细胞(A549)等的细胞毒活性. 结果显示, 含有糖苷结构的异维A酸衍生物明显比含有糖酯结构的异维A酸衍生物具有更好的细胞毒活性; 将糖环上的乙酰基脱去后, 相应的化合物活性有明显提高.     

13-cis-异维A酸衍生物的合成、表征及抗癌活性研究

以六甲基磷酰胺为溶剂,在室温条件下将异维A酸合成为尚未见文献报道的异维A酸衍生物(4a～4g),其结构经^1H NMR,^13C NMR和MS表征。着重考察了4g的生物活性,结果表明该4g对肝癌细胞,舌癌细胞等具有抗癌活性。     

异维A酸席夫碱酯的合成

以二环己基碳酰亚胺为脱水剂,4-二甲氨基吡啶为催化剂,异维A酸与对羟基苯胺发生酯化反应,生成异维A酸酯(1);1与醛反应,合成了4个异维A酸席夫碱酯,其结构经1H NMR和IR表征.     

异维A酸4-氨基安替比林席夫碱酯的合成

以二环己基碳酰亚胺为脱水剂,4-二甲氨基吡啶为催化剂,异维A酸与甲酰基酚发生酯化反应生成了异维A酸酯(1a~1d);1再与4-氨基安替比林反应,合成了4个异维A酸4-氨基安替比林席夫碱酯(2a~2d)。2的结构由1HNMR,IR和MS确证。     

二茂铁席夫碱的合成及细胞毒活性

为了研究二茂铁席夫碱对癌细胞毒性,以二茂铁甲醛或乙酰基二茂铁与3-取代-4-氨基-1,2,4-三唑-5-硫酮或酰肼缩合,得到6个新型的含二茂铁基的缩胺类席夫碱和4个酰腙类席夫碱.利用1H NMR,IR,MS谱和元素分析对化合物结构进行了表征.体外细胞测试结果表明,所有化合物对Hela (宫颈癌细胞)均有一定的抑制生长活性,而且杂环缩胺类席夫碱2的细胞毒活性要强于酰腙类席夫碱4.     

螯合物(FcCOCHCOCH3)2Cu与(FcCOCHCOCH3)3Fe的合成及其燃烧催化活性

含有铁、铬、铜等过渡元素的一些化合物,如铁的氧化物、铜的亚铬酸盐、二茂铁及其衍生物等都可作为复合固体推进剂的燃速催化剂.在二茂铁衍生物中主要是烷基衍生物,如叔丁基二茂铁、正辛基二茂铁、γ-二茂铁丁酸丁酯以及1,7-二(二茂铁基)庚烷、2,2-双(乙基二茂铁基)丙烷等.上述催化剂的变化趋势是由单二茂铁基向双二茂铁基发展,     

异海松酰(胺)基硫脲类衍生物的合成及其生物活性评价

为了开发具有较高生物活性的异海松酸类衍生物,将硫脲结构拼接到异海松酸骨架上,设计合成了15个未见报道的异海松酰(胺)基硫脲类化合物,其结构经FT-IR、~1H NMR、~(13)C NMR和HRMS或元素分析确证.对化合物进行了初步的抑菌和抗癌活性测试,大多数化合物对白色念珠菌表现出显著的抑制活性,且活性高于异海松酸.在浓度为100μmol/L时,部分化合物对人黑色素瘤(A375)和前列腺癌(PC-3)癌细胞具有明显的增殖抑制作用,尤其化合物N-异海松酰基-N′-(3-甲基苯基)硫脲(3c)和N-异海松酰胺基-N'-(4-氟苯基)硫脲(6b)对癌细胞的抑制率达到90%以上.     

2-巯基苯并咪唑衍生物的设计、合成及抗肿瘤活性研究

为了从苯并咪唑类衍生物中寻找新的活性化合物,以溴乙酸作为起始原料,设计合成了17个2-巯基苯并咪唑衍生物4a～4q。采用噻唑蓝(MTT)法测试了目标化合物对人宫颈癌细胞(He La)、人乳腺癌细胞(MCF-7)、人肝癌细胞(HepG2)、人非小细胞肺癌细胞(A549)的增殖抑制活性。结果显示,大部分化合物具有较好的抗肿瘤活性,其中,((1H-苯并[d]咪唑-2-基)硫基)-1-(4-二苯甲基哌嗪-1-基)乙烷-1-酮(4l)对HepG2细胞的抑制活性最好,IC_(50)值为12. 62±0. 78μmol/L,接近于对照药品吉非替尼(9. 72±0. 38μmol/L)。此外,利用分子对接方法对目标化合物的构效关系进行了讨论。     

新型腙基取代嘧啶衍生物的合成及抗肿瘤活性评价（英文）

为了寻找高效的新型抗肿瘤药物,设计并合成了一系列新型腙基取代的2,4,6-取代嘧啶衍生物,并对目标化合物在MCF-7(人乳腺癌细胞), MGC-803(人胃癌细胞系),PC-3(人前列腺癌细胞),Hela(人宫颈癌细胞)和A549(人肺癌细胞)进行抗肿瘤活性评价.结果显示部分化合物对PC-3表现出中度至强效的抗肿瘤活性.其中2-(丙-2-炔-1-基硫基)-4-(2-(吡啶-2-基亚甲基)-肼基)-6-(三氟甲基)嘧啶(12l)对PC-3具有较强的抗增殖活性, IC_(50)为1.37μmol·L~(-1),抗肿瘤活性明显优于阳性对照药5-氟尿嘧啶,为抗肿瘤药物的研究提供了新的思路.     

双二茂铁基吡咯衍生物电荷交互通道

以二茂铁炔烃为原料通过“一锅法”环加成反应合成了一系列2,5-双二茂铁基-1-苯基-吡咯衍生物, 包括: 2,5-双二茂铁基-1-(3-三氟甲基苯基)-吡咯(1), 2,5-双二茂铁基-1-(4-氟苯基)-吡咯(2), 2,5-双二茂铁基-1-苯基-吡咯(3), 2,5-双二茂铁基-1-(4-乙基苯基)-吡咯(4)和2,5-双二茂铁基-1-(4-乙氧基苯基)-吡咯(5), 使用元素分析, 傅里叶变换红外(FTIR)光谱, 质谱(MS)和核磁共振(NMR)等手段对化合物进行了结构表征. 采用循环伏安法(CV), 密度泛函理论(DFT)模拟计算研究了苯基上取代基对双二茂铁间电荷交互的影响. 研究发现第一氧化电位(E_a1), 峰电位差(ΔE)与取代基的哈米特常数(σ), 吡咯¹H NMR的化学位移(δ), 吡咯N原子自然轨道(NBO)电荷之间存在显著线性关联; 同时发现, N原子电荷密度升高, 双二茂铁间电荷交互能力减弱, N原子电荷密度降低, 双二茂铁间电荷交互能力提高. 因此这类双二茂铁基吡咯衍生物中N原子电荷密度对双二茂铁间电荷交互起着关键的影响作用.     

Design,synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines

A series of novel arylpiperazine derivatives was synthesized. The in vitro cytotoxic activities of all synthesized compounds against three human prostate cancer cell lines(PC-3, LNCa P, and DU145) were evaluated by a CCK-8 assay. Compounds 8, 10, 13, 17 and 20 exhibited strong cytotoxic activities against the tested cancer cell lines(IC_(50)3 μmol/L). In addition, these compounds exhibited weak cytotoxic effects on human epithelial prostate normal cells WPMY-1. The structure–activity relationship(SAR) of these arylpiperazine derivatives was also discussed based on the obtained experimental data.     

Iodine-catalyzed three-component one-pot synthesis of novel 1,8-dioxo-decahydroacridines derivatives bearing benzene sulfonamide moiety

An efficient synthetic method for 1,8-dioxo-decahydroacridines derivatives bearing the biologically active sulfonamide moiety is described. Aromatic aldehyde reacted with 5,5-dimethyl-1,3-cyclohexanedione and sulfanilamide, with molecular iodine as catalyst, to give 1,8-dioxo-decahydroacridines derivatives in high to excellent yield. The structures of these compounds were established on the basis of elemental (C, H and N) and spectral analysis (¹H NMR, ¹³C NMR, MS and FTIR). All the compounds were tested for their cytotoxic activity in vitro against three human tumor cell lines: human mammary cancer cells (MCF-7), human cervical carcinoma cells (Hela), and human lung cancer cells (A549) by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Most of them showed moderate to potent cytotoxic activity against the tested cell lines. Among them, the most active compound 4e exhibited more efficient activity (10.92 μM) against MCF-7 cells than cisplatin (11.06 μM).     

Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design,Anticancer Evaluation and Molecular Docking Targeting EGFR,VEGFR-2 and CDK-2

This study represents the design and synthesis of a new set of triazole-coumarin-glycosyl hybrids and their tetrazole hybrid analogues possessing various sugar moieties and modified analogues. All the newly synthesized derivatives were screened for their cytotoxic activities against a panel of human cancer cell lines. The coumarin derivatives 10, 13 and 15 derivatives revealed potent cytotoxic activities against Paca-2, Mel-501, PC-3 and A-375 cancer cell lines. These promising analogues were further examined for their inhibitory assessment against EGFR, VEGFR-2 and CDK-2/cyclin A2 kinases. The coumarin-tetrazole 10 displayed broad superior inhibitory activity against all screened enzymes compared with the reference drugs, erlotinib, sorafenib and roscovitine, respectively. The impact of coumarin-tetrazole 10 upon cell cycle and apoptosis induction was determined to detect its mechanism of action. Additionally, it upregulated the levels of casp-3, casp-7 and cytochrome-c proteins and downregulated the PD-1 level. Finally, molecular docking study was simulated to afford better rationalization and gain insight into the binding affinity between the promising derivatives and their targeted enzymes, which could be used as an optimum lead for further modification in the anticancer field.     

Flavonoid glycosides from Chromolaena odorata leaves and their in vitro cytotoxic activity

Two new flavonoid glycosides, (1, 2), and eleven known compounds, (3-13), were isolated from from a 70% EtOH extract of the leaves of Chromolaena odorata (Asteraceae). Their structures were elucidated by 1D and 2D NMR spectroscopic interpretation as well as by chemical studies. The newly isolated compounds were tested in vitro for their cytotoxic activities against the LLC and HL-60 cancer cell lines. Compound 1 showed cytotoxicity against LLC and HL-60 cancer cell lines with IC(50) values of 28.2 and 11.6 μM, respectively. Compound 2 exhibited significant cytotoxic activity in the inhibition of HL-60 cancer cell lines with IC(50) value of 10.8 μM.     

Synthesis and investigation of cytotoxicity of new N- and S,S-substituted-1,4-naphthoquinone (1,4-NQ) derivatives on selected cancer lines

1,4-Naphthoquinones (1,4-NQ) have been reported to possess a variety of pharma-cological properties including antibacterial, antifungal, antiviral, anti-inflammatory, anti-artherosclerotic, and anticancer effects. In this study, new N- and S,S-substituted-1,4-NQ derivatives were synthesized in excellent yields and were completely characterized by spectroscopic analysis IR, NMR (¹H and ¹³C), MS and microanalysis. The cytotoxic activities of 1,4-NQ derivatives were examined against to A-549, DU145, HCT-116 and MDA-MB-231 cancer cells. Among these compounds, 2-[4-(2-furoyl)piperazine-1-yl]-3-chloro-1,4-NQ 5 and 2,3-bis(cyclobuthylsulfanyl)-1,4-NQ 17 were identified as the most potent anticancer agents with cytotoxic activity against three cell lines (breast (MDA-MB-231), prostate (DU145), colorectal (HCT-116).     

Hyperisampsins N and O,two new benzoylated phloroglucinol derivatives from Hypericum sampsonii

Twenty-one benzoylated phloroglucinol derivatives bearing homoadamantyl frameworks were isolated from the aerial parts of Hypericum sampsonii, including two new ones named hyperisampsins N and O (1 and 2). The structures of 1 and 2 were elucidated by extensive NMR and mass spectrometric analyses. Their absolute configurations were further determined by using TDDFT ECD calculations. Compounds 2, 7, and 8 were evaluated for their cytotoxic activities against five human cancer cell lines, of which, 2 and 8 exhibited significant cytotoxic activities toward HL-60 cell and moderate activities against others cell lines.     

Design,Synthesis, Biological Evaluation and Silico Prediction of Novel Sinomenine Derivatives

Sinomenine is a morphinan alkaloid with a variety of biological activities. Its derivatives have shown significant cytotoxic activity against different cancer cell lines in many studies. In this study, two series of sinomenine derivatives were designed and synthesized by modifying the active positions C₁ and C₄ on the A ring of sinomenine. Twenty-three compounds were synthesized and characterized by spectroscopy (IR, ¹H-NMR, ¹³C-NMR, and HRMS). They were further evaluated for their cytotoxic activity against five cancer cell lines, MCF-7, Hela, HepG2, SW480 and A549, and a normal cell line, Hek293, using MTT and CCK8 methods. The chlorine-containing compounds exhibited significant cytotoxic activity compared to the nucleus structure of sinomenine. Furthermore, we searched for cancer-related core targets and verified their interaction with derivatives through molecular docking. The chlorine-containing compounds 5g, 5i, 5j, 6a, 6d, 6e, and 6g exhibited the best against four core targets AKT1, EGFR, HARS and KARS. The molecular docking results were consistent with the cytotoxic results. Overall, results indicate that chlorine-containing derivatives might be a promising lead for the development of new anticancer agents.     

大黄酸-缬氨酸加合物的合成及初步抗肿瘤活性

以大黄酸为原料,经酯化、烷基化、水解及缩合等反应步骤合成了12个大黄酸-缬氨酸加合物.目标化合物经1H NMR,~(13)C NMR和HRMS进行了结构确证.以顺铂和阿霉素为阳性对照药,采用四甲基偶氮唑盐(MTT)法考察了目标化合物的体外抗肿瘤(Hela,MCF-7,HepG2,KB和HEK293T等5株细胞)活性.结果表明,化合物5l显示出较好的抗肿瘤活性,其IC50值在1.6~9.4μmol/L之间.作用机制研究结果表明,化合物5l能够与DNA发生较强的结合作用.